Subcutaneous Drug Delivery Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Subcutaneous Drug Delivery Market by Product (Pen Injectors, Prefilled Syringes, Wearable Injectors), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and online Pharmacies), and Region (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Subcutaneous drug delivery market size was valued at USD 20.6 billion in the year 2020 and is anticipated to grow at USD 45.53 billion till 2027, witnessing a CAGR of around 12% during the forecast period from 2021 to 2027. The Subcutaneous drug delivery system is a workable alternative for intravenous administration system. Fast development of biologics gives rise to the use of subcutaneous drug delivery. The use of this system is mainly preferred due to its benefits such as improves quality of life, allows self-medication and consequently lessens healthcare costs. A few major factors contribute towards the growth of the global subcutaneous drug delivery market are expediency and protection provided by this system for medical experts and patients. Several health experts are suffered from infectious illnesses in 2014 as a consequent of needle stick wounds according to World Health Organization and this unique system works effectively to lessen the prevalence of needle stick damages. Subcutaneous drugs are given in the skin’s layer named cutis, which contains the dermis and epidermis. There are several pharmaceutical products developed and sold to treat different illnesses which are given through subcutaneous routes.

The report gives a comprehensive outlook on subcutaneous drug delivery market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Bn) on the basis of product, distribution Channel and region. This report studies global subcutaneous drug delivery market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global subcutaneous drug delivery.


Subcutaneous Drug Delivery Market

MARKET SUMMARY
-
12% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 12%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Subcutaneous Drug Delivery Market Analysis

  • Acquisitions and mergers also key strategies adopted by the market players to boost their market share.
  • For instance, In December 2019, Portal Instruments, Inc. teamed up with LEO Pharma for the improvement of a without needle subcutaneous medication conveyance gadget.
  • Additionally, the expanding pervasiveness of ongoing sickness conditions like numerous sclerosis, cardiovascular infections, diabetes, and joint inflammation contribute significantly to the development of the market for subcutaneous medication conveyance gadgets.
  • As indicated by the National Multiple Sclerosis Society, an expected 1.0 million grown-ups were accounted for to be living with different sclerosis in the U.S. in 2017.
Market Leaders
  • Gerresheimer AG
  • Insulet Corporation
  • Ypsomed AG
  • Unilife Corporation
  • West Pharmaceutical Services, Inc.
  • Novo Nordisk
  • Medtronic Plc
Subcutaneous Drug Delivery Market

Drivers and Restraints

There are many significant factors that contribute towards the growth of the subcutaneous drug deliver market and implementation of inorganic growth strategies by industry players is one of that. Key players focus more on inorganic strategies to give that important place to their products in the market. Growing focus on protecting the needle stick damage is given, which lead towards the growth of the market. Needle stick damages with lacing systems and injection needled are a major anxiety among diabetes patients. Growing alertness about safety and concern about needle stick damages are main factors booming the subcutaneous drug deliver market growth. The unavailability of the approved products because of rising number of product recalls by different developers is a market restricting factor.


North America dominates the market

Subcutaneous Drug Delivery Market

North America region dominated the market and obtained huge market share in the year 2019. This region is further anticipated to dominate the market during the forecast period. This region is evaluated to continue its dominance and maintained the market share because of the major key players working in the region, constant strategic initiatives followed by key players and developed healthcare infrastructure. The market is also projected to grow at profitable level in Asia pacific also during the forecast period. Due to the increasing cases of diabetic people, huge market growth is observed in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Subcutaneous Drug Delivery Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Gerresheimer AG
  • Insulet Corporation
  • Ypsomed AG
  • Unilife Corporation
  • West Pharmaceutical Services, Inc.
  • Novo Nordisk
  • Medtronic Plc
  • Elcam Medical Group
  • Becton, Dickinson and Company
  • PharmaJet
  • Inolife Sciences

Description

Subcutaneous drug delivery market size was valued at USD 20.6 billion in the year 2020 and is anticipated to grow at USD 45.53 billion till 2027, witnessing a CAGR of around 12% during the forecast period from 2021 to 2027. The Subcutaneous drug delivery system is a workable alternative for intravenous administration system. Fast development of biologics gives rise to the use of subcutaneous drug delivery. The use of this system is mainly preferred due to its benefits such as improves quality of life, allows self-medication and consequently lessens healthcare costs. A few major factors contribute towards the growth of the global subcutaneous drug delivery market are expediency and protection provided by this system for medical experts and patients. Several health experts are suffered from infectious illnesses in 2014 as a consequent of needle stick wounds according to World Health Organization and this unique system works effectively to lessen the prevalence of needle stick damages. Subcutaneous drugs are given in the skin’s layer named cutis, which contains the dermis and epidermis. There are several pharmaceutical products developed and sold to treat different illnesses which are given through subcutaneous routes.

The report gives a comprehensive outlook on subcutaneous drug delivery market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Bn) on the basis of product, distribution Channel and region. This report studies global subcutaneous drug delivery market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global subcutaneous drug delivery.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX